Search Results

BioForest

PhaseRx Receives Decision From the Nasdaq Hearings Panel for Continued Listing of Shares

PhaseRx today announced it received a decision from the Nasdaq Hearings Panel granting PhaseRx’s request for continued listing on The Nasdaq Capital Market until January 31, 2018.

December 13, 2017

·

5 min read

BioForest

PhaseRx Receives Delisting Notice From Nasdaq and Evaluates Listing Options

PhaseRx today announced receipt of a delisting notice from Nasdaq, which informed the company that, absent an appeal, trading in PhaseRx’s common stock will be suspended from Nasdaq at the opening of business on November 1, 2017.

October 26, 2017

·

4 min read

Business

Seattle’s PhaseRx Cuts 50% of Employees, Including Some Exec Officers

PhaseRx has undertaken a strategic restructuring that includes the termination of 50 percent of its staff.

October 13, 2017

·

2 min read

Drug Development

PhaseRx Receives Positive Opinion for Orphan Drug Designation for PRX-ASL From EMA

PhaseRx today announced that the EMA’s Committee for Orphan Medicinal Products has issued a positive opinion recommending orphan medicinal product designation for PRX-ASL, for the treatment of ASLD, PhaseRx’s second drug candidate to treat a urea cycle disorder.

November 28, 2017

·

5 min read

Deals

Seattle’s PhaseRx Files for Bankruptcy as it Considers Partner, Merger or Sale Options

The company indicates it plans to continue to manage and operate under the bankruptcy filing while it works with Cowen and Company to develop a plan forward.

December 11, 2017

·

2 min read

·

Mark Terry

Business

PhaseRx Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Total operating expenses for the third quarter of 2017 were $2.5 million, compared to $3.1 million of operating expenses in the third quarter of 2016.

November 9, 2017

·

11 min read

Business

PhaseRx Reports Second Quarter 2017 Financial Results And Provides Corporate Update

August 10, 2017

·

1 min read

BioForest

PhaseRx To Present At The 2016 Aegis Growth Conference

September 14, 2016

·

1 min read

Business

PhaseRx Appoints Peggy Phillips To Board Of Directors

August 23, 2016

·

2 min read

BioForest

PhaseRx To Present Company Overview At Upcoming Investor Conferences

October 11, 2016

·

1 min read